IVX ASX Chart
Snapshot
Invion Limited (IVX) is a life-science company that is leading the global research and development of the Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. Invion holds the exclusive Australia and New Zealand license rights and exclusive distribution rights to Asia Pacific excluding China (other than Hong Kong, which is included in the Territory), Macau, Taiwan, Japan and South Korea to the Photosoft technology for all cancer indications.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -70.53% |
vs ASX 200 (1yr) | -81.59% |
Announcements
Corporate Overview
Corporate Details
Head Office | Kew East VIC 3102 |
Website | www.inviongroup.com |
Registry | BoardRoom |
Auditor | William Buck Audit (VIC) Pty Ltd |
Date Listed | 15 Feb 2010 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/08/2025 | Report (Annual) |
Former Company Names
- Cbio Limited (CBZ), 04/09/2012.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
IVX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of IVX directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Honsue Cho | 21/08/2024 | 1,146,031,359 | 17.84 |
Shengli Wang and associates | 21/08/2024 | 408,940,371 | 6.37 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
05-06-24 | Unlimited Innovation Group Limited | 321,428,571 | 22.9 | 17.8 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.004 | 28 June |
2023 | $0.004 | 30 June |
2022 | $0.009 | 30 June |
2021 | $0.013 | 30 June |
2020 | $0.008 | 30 June |
2019 | $0.015 | 28 June |
2018 | $0.034 | 29 June |
2017 | $0.002 | 30 June |
2016 | $0.004 | 30 June |
2015 | $0.019 | 30 June |
2014 | $0.07 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.